Side Effects of Transesophageal Echocardiography
Local Side Effects of Transesophageal Echocardiography
1 other identifier
interventional
10
1 country
1
Brief Summary
Transesophageal echocardiography is commonly used during cardiac surgery. Complications of transesophageal echocardiography are rare (1,2%), but are often underestimated and can lead to unrecognized blood loss and site of infection. This study wants to assess the mucosa of pharynx, upper larynx, esophagus and stomach prior to and after echo probe insertion during cardiac surgery with endoscopy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2009
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2018
CompletedFirst Submitted
Initial submission to the registry
February 1, 2018
CompletedFirst Posted
Study publicly available on registry
February 14, 2018
CompletedFebruary 14, 2018
February 1, 2018
9 months
February 1, 2018
February 7, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
incidence of endoscopic mild mucosal injury
erythema, edema, hematoma, mucosal erosion, petechiae, or perforation of the upper GI mucosa
7-8 hours
Secondary Outcomes (2)
length of examination
1 day
incidence of postoperative complications
up to 1 week
Study Arms (1)
endoscopy
OTHERendoscopy of the upper GI tract
Interventions
endoscopy of pharynx, upper esophagus, mid esophagus, cardia, gastric fundus, und gastric body
Eligibility Criteria
You may qualify if:
- Planned cardiac surgery
- Age above 18 years
- Signed informed consent
- Clinical need for intraoperative use of transesophageal echocardiography
You may not qualify if:
- Recent gastrointestinal pathologies (3-6 months)
- Recent operations of the upper gastrointestinal tract (3-6 months)
- Subjects not able to understand study procedures
- No signed informed consent
- Contraindications for transesophageal echocardiography
- Antibiotic treatment within three months prior to surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Medical University of Vienna
Vienna, 1090, Austria
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ulrike Weber, M.D.Ph.D.
Medical University of Vienna
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Masking Details
- the investigator doing the transesophageal examination will not be informed about the results of the endoscopy
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Ass.Prof.Dr.
Study Record Dates
First Submitted
February 1, 2018
First Posted
February 14, 2018
Study Start
July 1, 2009
Primary Completion
March 31, 2010
Study Completion
January 31, 2018
Last Updated
February 14, 2018
Record last verified: 2018-02
Data Sharing
- IPD Sharing
- Will not share